Psychiatric characterization of children with genetic causes of hyperandrogenism

European Journal of Endocrinology

Volumn 163, Issue 5, 2010, Pages 801-810

  Mueller, Sven C ^a   Ng, Pamela ^a,e   Sinaii, Ninet ^b   Leschek, Ellen W ^c   Green Golan, Liza ^b   VanRyzin, Carol ^b   Ernst, Monique ^a   Merke, Deborah P ^b,d  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANDROGEN; FLUDROCORTISONE; GONADORELIN DERIVATIVE; HYDROCORTISONE; SPIRONOLACTONE; STEROID 11BETA MONOOXYGENASE;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ANALYSIS OF VARIANCE; ANOREXIA NERVOSA; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; AVOIDANT PERSONALITY DISORDER; BONE AGE; CHILD; CHILD PSYCHIATRY; CIGARETTE SMOKING; CLINICAL EVALUATION; COMORBIDITY; CONDUCT DISORDER; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DRUG ABUSE; EARLY DIAGNOSIS; EARLY INTERVENTION; ENURESIS; FAMILIAL MALE PRECOCIOUS PUBERTY; FECES INCONTINENCE; FEMALE; GENERALIZED ANXIETY DISORDER; GENETIC DISORDER; HORMONE SUBSTITUTION; HUMAN; HYPERANDROGENISM; HYPOMANIA; LEARNING DISORDER; MAJOR DEPRESSION; MALE; MANIA; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; OPPOSITIONAL DEFIANT DISORDER; PANIC; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; SCHOOL CHILD; SEMI STRUCTURED INTERVIEW; SEPARATION ANXIETY; SOCIAL PHOBIA; SOCIAL STATUS; TIC; ANXIETY; CLINICAL TRIAL; COMPARATIVE STUDY; GENETICS; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ANXIETY; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; FEMALE; HUMANS; HYPERANDROGENISM; MALE; MENTAL DISORDERS; PUBERTY, PRECOCIOUS;

EID: 77957832382     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0693     Document Type: Article

References (66)

1. Levitt P. Structural and functional maturation of the developing primate brain. Journal of Pediatrics 2003 143 S35-S45. (doi:10.1067/S0022-3476(03)00400- 1) (Pubitemid 37346692)
2. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF III, Herman DH, Clasen LS, Toga AW, Rapoport JL & Thompson PM. Dynamic mapping of human cortical development during childhood through early adulthood. PNAS 2004 101 8174-8179. (doi:10.1073/pnas.0402680101)
3. Paus T, Nawaz-Khan I, Leonard G, Perron M, Pike GB, Pitiot A, Richer L, Susman E, Veillette S & Pausova Z. Sexual dimorphism in the adolescent brain: role of testosterone and androgen receptor in global and local volumes of grey and white matter. Hormones and Behavior 2009 57 63-75. (doi:10.1016/j.yhbeh.2009.08.004)
4. Neufang S, Specht K, Hausmann M, Gunturkun O, Herpertz-Dahlmann B, Fink GR & Konrad K. Sex differences and the impact of steroid hormones on the developing human brain. Cerebral Cortex 2009 19 464-473. (doi:10.1093/cercor/ bhn100)
5. Parylak SL, Caster JM, Walker QD & Kuhn CM. Gonadal steroids mediate the opposite changes in cocaine-induced locomotion across adolescence in male and female rats. Pharmacology, Biochemistry, and Behavior 2008 89 314-323. (doi:10.1016/j.pbb.2008.01.003)
6. Schulz KM, Zehr JL, Salas-Ramirez KY & Sisk CL. Testosterone programs adult social behavior before and during, but not after, adolescence. Endocrinology 2009 150 3690-3698. (doi:10.1210/en.2008-1708)
7. Baron-Cohen S, Knickmeyer RC & Belmonte MK. Sex differences in the brain: implications for explaining autism. Science 2005 310 819-823. (doi:10.1126/science.1115455)
8. Peterson BS, Leckman JF, Scahill L, Naftolin F, Keefe D, Charest NJ & Cohen DJ. Steroid hormones and CNS sexual dimorphisms modulate symptom expression in Tourette's syndrome. Psychoneuroendocrinology 1992 17 553-563. (doi:10.1016/0306-4530(92)90015-Y)
9. Pastor PN & Reuben CA. Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006. National Center for Health Statistics. Vital and Health Statistics 2008 10 1-14.
10. Nock MK, Kazdin AE, Hiripi E & Kessler RC. Prevalence, subtypes, and correlates of DSM-IV conduct disorder in the National Comorbidity Survey Replication. Psychological Medicine 2006 36 699-710. (doi:10.1017/ S0033291706007082)
11. Comings DE, Chen C, Wu S & Muhleman D. Association of the androgen receptor gene (AR) with ADHD and conduct disorder. Neuroreport 1999 10 1589-1592. (doi:10.1097/00001756-199905140-00036) (Pubitemid 29354352)
12. Brieber S, Neufang S, Bruning N, Kamp-Becker I, Remschmidt H, Herpertz-Dahlmann B, Fink GR & Konrad K. Structural brain abnormalities in adolescents with autism spectrum disorder and patients with attention deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry 2007 48 1251-1258. (doi:10.1111/j.1469-7610.2007.01799.x)
13. Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS, Blumenthal JD, James RS, Ebens CL, Walter JM, Zijdenbos A, Evans AC, Giedd JN & Rapoport JL. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Medical Association 2002 288 1740-1748. (doi:10.1001/jama.288. 14.1740)
14. Wang J, Jiang T, Cao Q & Wang Y. Characterizing anatomic differences in boys with attention-deficit/hyperactivity disorder with the use of deformation-based morphometry. AJNR. American Journal of Neuroradiology 2007 28 543-547.
15. McAlonan GM, Suckling J, Wong N, Cheung V, Lienenkaemper N, Cheung C & Chua SE. Distinct patterns of grey matter abnormality in high-functioning autism and Asperger's syndrome. Journal of Child Psychology and Psychiatry 2008 49 1287-1295. (doi:10.1111/j.1469-7610.2008.01933.x)
16. Merke DP & Bornstein SR. Congenital adrenal hyperplasia. Lancet 2005 365 2125-2136. (doi:10.1016/S0140-6736(05)66736-0)
17. Dittmann RW, Kappes MH, Kappes ME, Borger D, Stegner H, Willig RH & Wallis H. Congenital adrenal hyperplasia. I: Gender-related behavior and attitudes in female patients and sisters. Psychoneuroendocrinology 1990 15 401-420. (doi:10.1016/0306-4530(90)90065-H)
18. Pasterski V, Hindmarsh P, Geffner M, Brook C, Brain C & Hines M. Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH). Hormones and Behavior 2007 52 368-374. (doi:10.1016/j.yhbeh.2007.05.015)
19. Berenbaum SA & Snyder E. Early hormonal influences on childhood sex-typed activity and playmate preferences: implications for the development of sexual orientation. Developmental Psychology 1995 31 31-42. (doi:10.1037/0012-1649.31.1.31)
20. Mathews GA, Fane BA, Conway GS, Brook CG & Hines M. Personality and congenital adrenal hyperplasia: possible effects of prenatal androgen exposure. Hormones and Behavior 2009 55 285-291. (doi:10.1016/j.yhbeh.2008.11.007)
21. Berenbaum SA & Resnick SM. Early androgen effects on aggression in children and adults with congenital adrenal hyperplasia. Psychoneuroendocrinology 1997 22 505-515. (doi:10.1016/S0306-4530(97)00049-8)
22. Achenbach TM & Edelbrock C. Manual for the Child Behavior Checklist and Revised Child Behavior Profile Burlington, VT: Queen City Printers, 1983.
23. Berenbaum SA, Korman Bryk K, Duck SC & Resnick SM. Psychological adjustment in children and adults with congenital adrenal hyperplasia. Journal of Pediatrics 2004 144 741-746. (doi:10.1016/j.jpeds.2004.03.037)
24. Meyer-Bahlburg HFL, Dolezal C, Baker SW, Ehrhardt AA & New MI. Gender development in women with congenital adrenal hyperplasia as a function of disorder severity. Archives of Sexual Behavior 2006 35 667-684. (doi:10.1007/s10508-006-9068-9) (Pubitemid 44900401)
25. Knickmeyer R, Baron-Cohen S, Fane BA, Wheelwright S, Mathews GA, Conway GS, Brook CGD & Hines M. Androgens and autistic traits: a study of individuals with congenital adrenal hyperplasia. Hormones and Behavior 2006 50 148-153. (doi:10.1016/j.yhbeh.2006.02.006)
26. Laue L, Kenigsberg D, Pescovitz OH, Hench KD, Barnes KM, Loriaux DL & Cutler GB Jr. Treatment of familial male precocious puberty with spironolactone and testolactone. New England Journal of Medicine 1989 320 496-502. (doi:10.1056/NEJM198902233200805)
27. Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T & Cutler GB Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993 365 652-654. (doi:10.1038/ 365652a0)
28. Latronico AC, Anasti J, Arnhold IJ, Mendonca BB, Domenice S, Albano MC, Zachman K, Wajchenberg BL & Tsigos C. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty. Journal of Clinical Endocrinology and Metabolism 1995 80 2490-2494. (doi:10.1210/jc.80.8.2490)
29. Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D & Ryan N. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry 1997 36 980-988. (doi:10.1097/00004583-199707000-00021)
30. Wassenberg R, Max JE, Koele SL & Firme K. Classifying psychiatric disorders after traumatic brain injury and orthopaedic injury in children: adequacy of K-SADS versus CBCL. Brain Injury 2004 18 377-390. (doi:10.1080/02699050310001617325) (Pubitemid 38232730)
31. Leschek EW. Familial male-limited precocious puberty. Endocrinologist 2004 14 148-151. (doi:10.1097/01.ten.0000127927.01216.90)
32. Marshall WA & Tanner JM. Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood 1969 44 291-303. (doi:10.1136/adc.44. 235.291)
33. Zachmann M, Prader A, Kind HP, Hafliger H & Budliger H. Testicular volume during adolescence. Cross-sectional and longitudinal studies. Helvetica Paediatrica Acta 1974 29 61-72.
34. Hollingshead A. Four Factor Index of Social Status. Unpublished manuscript, Department of Sociology, Yale University, New Haven, CT, 1975.
35. Centers for Disease Control and Prevention. In Epi Info version 3.32, Department of Health and Human Services, CDC, USA 2000.
36. Zahn-Waxler C, Shirtcliff EA & Marceau K. Disorders of childhood and adolescence: gender and psychopathology. Annual Review of Clinical Psychology 2008 4 275-303. (doi:10.1146/annurev.clinpsy.3.022806.091358)
37. Merikangas KR, He J-P, Brody D, Fisher PW, Bourdon K & Koretz DS. Prevalence and Treatment of Mental Disorders Among US Children in the 2001-2004 NHANES. Pediatrics 2010 125 75-81. (doi:10.1542/peds.2008-2598)
38. Ford T, Goodman R & Meltzer H. The British Child and Adolescent Mental Health Survey 1999: the prevalence of DSM-IV disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2003 42 1203-1211. (doi:10.1097/00004583-200310000-00011)
39. Davies S, Heyman I & Goodman R. A population survey of mental health problems in children with epilepsy. Developmental Medicine and Child Neurology 2003 45 292-295. (doi:10.1111/j.1469-8749.2003.tb00398.x)
40. Rubinow DR & Schmidt PJ. Androgens, brain, and behavior. American Journal of Psychiatry 1996 153 974-984.
41. van Goozen SH, van den Ban E, Matthys W, Cohen-Kettenis PT, Thijssen JH & van Engeland H. Increased adrenal androgen functioning in children with oppositional defiant disorder: a comparison with psychiatric and normal controls. Journal of the American Academy of Child and Adolescent Psychiatry 2000 39 1446-1451. (doi:10.1097/00004583-200011000-00020)
42. Nigg JT. What Causes ADHD? Understanding What Does Wrong and Why New York: The Guilford Press, 2006.
43. Bradshaw JL. Developmental Disorders of the Frontostriatal System: Neuropsychological, Neuropsychiatric and Evoluntionary Perspectives New York: Psychology Press, 2002.
44. Biederman J & Faraone SV. Attention-deficit hyperactivity disorder. Lancet 2005 366 237-248. (doi:10.1016/S0140-6736(05)66915-2)
45. Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, Hackett G & Hines M. Fetal testosterone predicts sexually differentiated childhood behavior in girls and in boys. Psychological Science 2009 20 144-148. (doi:10.1111/j.1467-9280.2009.02279.x)
46. Martel MM, Gobrogge KL, Breedlove SM & Nigg JT. Masculinized finger-length ratios of boys, but not girls, are associated with attention-deficit/hyperactivity disorder. Behavioral Neuroscience 2008 122 273-281. (doi:10.1037/0735-7044.122.2.273)
47. Arborelius L, Owens MJ, Plotsky PM & Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. Journal of Endocrinology 1999 160 1-12. (doi:10.1677/joe.0.1600001) (Pubitemid 29044562)
48. Shepard JD, Barron KW & Myers DA. Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior. Brain Research 2000 861 288-295. (doi:10.1016/S0006-8993(00)02019-9)
49. Merke DP, Fields JD, Keil MF, Vaituzis AC, Chrousos GP & Giedd JN. Children with classic congenital adrenal hyperplasia have decreased amygdala volume: potential prenatal and postnatal hormonal effects. Journal of Clinical Endocrinology and Metabolism 2003 88 1760-1765. (doi:10.1210/jc.2002-021730)
50. Milad MR, Igoe SA, Lebron-Milad K & Novales JE. Estrous cycle phase and gonadal hormones influence conditioned fear extinction. Neuroscience 2009 164 887-895. (doi:10.1016/j.neuroscience.2009.09.011)
51. Clark AS & Henderson LP. Behavioral and physiological responses to anabolic-androgenic steroids. Neuroscience and Biobehavioral Reviews 2003 27 413-436. (doi:10.1016/S0149-7634(03)00064-2)
52. Sandyk R, Bamford CR, Binkiewicz A & Finley PR. Gonadotropin deficiency in Tourette's syndrome: a preliminary communication. International Journal of Neuroscience 1988 42 121-125. (doi:10.3109/00207458808985766)
53. Peterson BS, Zhang H, Anderson GM & Leckman JF. A double-blind, placebo-controlled, crossover trial of an antiandrogen in the treatment of Tourette's syndrome. Journal of Clinical Psychopharmacology 1998 18 324-331. (doi:10.1097/00004714-199808000-00013)
54. Leckman JF & Scahill L. Possible exacerbation of tics by androgenic steroids. New England Journal of Medicine 1990 322 1674.
55. Rutter TJ & Whitmore K. Education, Health, and Behavior London: Longmans, Green & Co., 1970.
56. Costello EJ, Mustillo S, Erkanli A, Keeler G & Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Archives of General Psychiatry 2003 60 837-844. (doi:10.1001/archpsyc.60.8.837) (Pubitemid 36960915)
57. Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME, Lahey BB, Bourdon K, Jensen PS, Bird HR, Canino G, Regier DA & The NIMH. Diagnostic Interview Schedule for Children Version 2.3 (DISC- 2.3): description, acceptability, prevalence rates, and performance in the MECA study. Journal of the American Academy of Child and Adolescent Psychiatry 1996 35 865-877. (doi:10.1097/00004583-199607000-00012)
58. Zavala J, Ramirez M, Medina R, Heard P, Carter E, Crandall A, Hale D, Cody J & Escamilla M. Psychiatric syndromes in individuals with chromosome 18 abnormalities. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 2010 153B 837-845.
59. Ghanizadeh A. Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample. International Journal of Dermatology 2008 47 1118-1120. (doi:10.1111/j.1365-4632.2008.03743.x)
60. Cadman D, Boyle M, Szatmari P & Offord DR. Chronic illness, disability, and mental and social well-being: findings of the Ontario Child Health Study. Pediatrics 1987 79 805-813.
61. Kovacs M, Goldston D, Obrosky DS & Bonar LK. Psychiatric disorders in youths with IDDM: rates and risk factors. Diabetes Care 1997 20 36-44. (doi:10.2337/diacare.20.1.36) (Pubitemid 27020039)
62. Blanz BJ, Rensch-Riemann BS, Fritz-Sigmund DI & Schmidt MH. IDDM is a risk factor for adolescent psychiatric disorders. Diabetes Care 1993 16 1579-1587. (doi:10.2337/diacare.16.12.1579)
63. Popkin MK, Callies AL, Lentz RD, Colon EA & Sutherland DE. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus. Archives of General Psychiatry 1988 45 64-68.
64. Kelly WF. Psychiatric aspects of Cushing's syndrome. Quarterly Journal of Medicine 1996 89 543-551.
65. Robins LN, Helzer JE, Weissman MM, Orvaschel H, Gruenberg E, Burke JD & Regier DA. Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry 1984 41 949-958.
66. Myers JK, Weissman MM, Tischler GL, Holzer CE, Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke JD, Kramer H & Stoltzman R. Six month prevalence of psychiatric disorders in three communities. Archives of General Psychiatry 1984 41 959-967.